Back

Impact of new-onset rhythm disturbances on left ventricular function and survival in TAVI patients with reduced ejection fraction: a retrospective cohort analysis

13 May 2024 (09:00 - 09:45)
Organised by: Logo
Congress Presentation Part of: Valvular heart disease 1 Intervention HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Andre Lobo

Unidade local de Saude Gaia/Espinho EPE, Vila Nova de Gaia (Portugal)

7 More presentations in this session

Presentation thumbnail
Percutaneous coronary revascularization timing in patients undergoing transcatheter aortic valve implantation
Doctor R. Carvalheiro (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Post- TAVI care: assessing the need for cardiac device implantation
Doctor A. Abrantes (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Transcatheter mitral valve repair: 10-year experience from a Portuguese tertiary care center
Doctor F. Barbas De Albuquerque (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Shor-term and long-term outcomes in transcatheter versus surgical aortic valve replacement
Ms G. Ramantauskaite (Kaunas, LT)
Abstract Slides Video
Presentation thumbnail
30-day and 1-year mortality after transcatheter aortic valve replacement: the impact of balloon aortic valvuloplasty as a bridging therapy in a Portuguese tertiary center
Doctor F. Barbas De Albuquerque (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Valvular heart disease 1

The Event

Event poster

Heart Failure 2024

13 May 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Left ventricular ejection fraction improvement after transcatheter aortic valve replacement: predictors and prognosis
thumbnail
Congress Presentation
Unlocking recovery: predictors and outcomes of left ventricular dysfunction after TAVI
thumbnail
Congress Presentation
The impact of persistent LBBB After TAVI: unraveling its effect on cardiac function and survival

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources